Insider track record
OtherNot enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the complete record of transactions filed by Savitz Ryan. Officer active across 1 company, notably Dianthus Therapeutics, Inc. /DE/. Cumulatively, 18 reports have been recorded. Split: 0 buy · 12 sells. Total volume traded: €11.6m. Activity tracked since 9 September 2025. The latest transaction was filed on 9 July 2026 (Cession). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Savitz Ryan
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations18 total
5,566 shares@ US$101.97Common StockSEC:0001992324-26-000008:3
31,249 shares@ US$21.77Common StockSEC:0001992324-26-000008:0
10,354 shares@ US$100.22Common StockSEC:0001992324-26-000008:1
15,329 shares@ US$101.24Common StockSEC:0001992324-26-000008:2
8,224 shares@ US$17.8816.6% of flowCommon StockSEC:0001992324-26-000006:0
8,224 shares@ US$89.8483.4% of flowCommon StockSEC:0001992324-26-000006:1
74,367 shares@ US$8.445.4% of flowCommon StockSEC:0001992324-26-000004:0
40,000 shares@ US$17.886.1% of flowCommon StockSEC:0001992324-26-000004:1
1,390 shares@ US$78.330.9% of flowCommon StockSEC:0001992324-26-000004:2
21,825 shares@ US$78.8614.7% of flowCommon StockSEC:0001992324-26-000004:3
1,485 shares@ US$80.251.0% of flowCommon StockSEC:0001992324-26-000004:4
800 shares@ US$81.360.6% of flowCommon StockSEC:0001992324-26-000004:5
2,366 shares@ US$82.841.7% of flowCommon StockSEC:0001992324-26-000004:6
59,800 shares@ US$83.9042.8% of flowCommon StockSEC:0001992324-26-000004:7
19,469 shares@ US$84.5714.1% of flowCommon StockSEC:0001992324-26-000004:8
7,232 shares@ US$85.545.3% of flowCommon StockSEC:0001992324-26-000004:9
20,000 shares@ US$8.441.4% of flowCommon StockSEC:0001992324-25-000005:0
20,000 shares@ US$8.441.4% of flowCommon StockSEC:0000950170-25-114293:0
About Savitz Ryan
Savitz Ryan is a declarant linked to Dianthus Therapeutics, Inc. /DE/ on XNAS, where the listed role is EVP, CFO & CBO. Across 12 total filings, the 12 sampled filings run from 2026-04-01 to 2026-04-10 and show 0 EUR of purchases and 8833471 EUR of sales, with the modal transaction nature listed as sale.